Wilmington, DE, United States of America

Lynn A Arlauskas

This inventor holds 1 USPTO granted patent. Top assignee: Cellpro Incorporated. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lynn A Arlauskas. Retrieved from https://idiyas.com/inventor/lynn-a-arlauskas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lynn A. Arlauskas: Innovator in Cell Isolation Technology

Introduction

Lynn A. Arlauskas is a notable inventor based in Wilmington, DE (US). She has made significant contributions to the field of cell isolation technology. Her innovative work has led to the development of a patented process that enhances the efficiency of isolating specific cells.

Latest Patents

Lynn A. Arlauskas holds a patent for a "Multiple stage affinity process for isolation of specific cells." This invention allows for the positive separation of desired cells from a mixture using multiple stages of affinity surfaces. The bound cells from each surface are removed and subjected to further surfaces for additional enrichment. This process is crucial for applications in research and medical fields.

Career Highlights

Lynn is currently employed at Cellpro Incorporated, where she continues to advance her research and development efforts. Her work at Cellpro has positioned her as a key player in the biotechnology sector, focusing on innovative solutions for cell separation and isolation.

Collaborations

Lynn collaborates with her coworker, Dale R. Peterson, to further enhance their research initiatives. Together, they work on projects that aim to improve the efficiency and effectiveness of cell isolation techniques.

Conclusion

Lynn A. Arlauskas is a pioneering inventor whose work in cell isolation technology has made a significant impact in the field. Her patented process demonstrates her commitment to advancing scientific research and medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…